Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Skinvisible Inc
(OP:
SKVI
)
0.2970
UNCHANGED
Streaming Delayed Price
Updated: 2:22 PM EST, Dec 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Skinvisible Inc
Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development
October 03, 2024
Via
ACCESSWIRE
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible
July 11, 2024
Via
ACCESSWIRE
Skinvisible Unveils Promising Data on Transdermal Obesity Formulations
July 09, 2024
Via
ACCESSWIRE
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
June 24, 2024
Via
ACCESSWIRE
Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment
May 29, 2024
Via
ACCESSWIRE
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
February 14, 2024
Via
ACCESSWIRE
Why Are Quoin Pharma Shares Trading Higher Today?
June 06, 2022
Via
Benzinga
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
June 06, 2022
LAS VEGAS, NV / ACCESSWIRE / June 6, 2022 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that its licensee Quoin Pharmaceuticals, Inc. ("Quoin") (NASDAQ:QNRX), has received...
From
Skinvisible Inc
Via
AccessWire
Exposures
Product Safety
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.